To assess the field of muscular and anhidrotic effects of 2 commercial preparations of BoNT-A ( incobotulinumtoxinA : Xeomin [ XEO ] ; abobotulinumtoxinA : Dysport [ DYS ] ) administered to the upper third of the face .